ERBB2 and breast carcinoma: Consequently, this study aimed to assess the prognostic value of a 22‐gene mutational profile obtained via targeted sequencing of primary breast cancer specimens from patients with ER+/ERBB2‐ EBC archived in the tissue bank under an extended follow‐up.